GlassScriptPhysician profile
Brenna Baynard-Smith
NPI 1932195542
$1,983.48
in general payments reported to CMS, 2019-2025
17 companies · $409 in 2025
The $409 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $431 · 2020: $208 · 2021: $238 · 2022: $270 · 2023: $213 · 2024: $215 · 2025: $409.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $826 · Education: $11.29.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $826.48 |
| Education | $11.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $633.26 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Corcept Therapeutics | $291.54 | 2024-2025 | Korlym |
| Janssen Pharmaceuticals, INC | $234.18 | 2019-2020 | |
| Lilly USA, LLC | $207.69 | 2019-2024 | Mounjaro |
| Abbott Laboratories | $195.17 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $111.57 | 2022-2023 | |
| Eisai INC. | $55.77 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $47.39 | 2020-2021 | |
| Sanofi-Aventis U.S. LLC | $35.00 | 2019-2021 | |
| Dexcom, INC. | $28.26 | 2024 | Dexcom G6 Transmitter |
| Biohaven Pharmaceutical Holding Company LTD. | $23.63 | 2022 | |
| Philips North America LLC | $22.24 | 2023 | |
| Abbvie INC. | $22.19 | 2022 | |
| Exact Sciences Corporation | $20.97 | 2025 | Cologuard Collection Kit |
| Lucid Diagnostics INC. | $19.64 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $17.57 | 2021 | |
| Hologic Sales and Service, LLC | $17.41 | 2023 | Thinprep 2000 Processor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brenna Baynard-Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.